We are live on ! Find out more
MCP

Martin Capital Partners Portfolio holdings

AUM $272M
1-Year Est. Return 19.09%
This Fund
S&P 500
This Quarter Est. Return
+6.84%
1 Year Est. Return
+19.09%
3 Year Est. Return
+35.19%
5 Year Est. Return
+47.96%
10 Year Est. Return
AUM
$245M
AUM Growth
+$7.67M
Cap. Flow
-$6.48M
Cap. Flow %
-2.64%
Top 10 Hldgs %
30.91%
Holding
73
New
1
Increased
7
Reduced
57
Closed
3

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$5.27M
2
HON icon
Honeywell
HON
+$4.57M
3
VZ icon
Verizon
VZ
+$708K
4
PFE icon
Pfizer
PFE
+$571K
5
SCHD icon
Schwab US Dividend Equity ETF
SCHD
+$570K

Sector Composition

Rank Sector Weight
1 Healthcare 16.44%
2 Industrials 16.16%
3 Consumer Staples 13.58%
4 Technology 10.53%
5 Financials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOF icon
26
Coca-Cola Femsa
KOF
$23B
$5.2M 2.12%
54,920
-336
-0.6% -$28K
TROW icon
27
T. Rowe Price
TROW
$24.1B
$5.18M 2.11%
48,136
+3,169
+7% +$316K
IGSB icon
28
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$5.15M 2.1%
100,477
-2,294
-2% -$115K
UPS icon
29
United Parcel Service
UPS
$88.2B
$5.02M 2.05%
31,945
-923
-3% -$140K
UNH icon
30
UnitedHealth
UNH
$367B
$4.92M 2%
9,340
-122
-1% -$65.1K
PSX icon
31
Phillips 66
PSX
$81.8B
$4.63M 1.89%
34,741
-522
-1% -$62.4K
TTE icon
32
TotalEnergies
TTE
$191B
$4.57M 1.86%
67,782
-764
-1% -$50.9K
SHY icon
33
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$4.18M 1.7%
50,943
-392
-0.8% -$31.9K
CLX icon
34
Clorox
CLX
$12.8B
$3.83M 1.56%
26,839
-391
-1% -$52.1K
PEP icon
35
PepsiCo
PEP
$188B
$3.77M 1.54%
22,214
-643
-3% -$107K
STIP icon
36
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$3.56M 1.45%
36,118
-621
-2% -$60.5K
GILD icon
37
Gilead Sciences
GILD
$160B
$3.33M 1.36%
41,064
-447
-1% -$34.8K
SWKS icon
38
Skyworks Solutions
SWKS
$10B
$3.2M 1.3%
28,442
-5,195
-15% -$508K
DVN icon
39
Devon Energy
DVN
$49.6B
$2.49M 1.02%
54,989
-10,676
-16% -$489K
PFE icon
40
Pfizer
PFE
$147B
$2.41M 0.98%
83,582
-18,892
-18% -$571K
SDY icon
41
State Street SPDR S&P Dividend ETF
SDY
$23.7B
$2.37M 0.97%
18,961
+15,102
+391% +$1.77M
IEI icon
42
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
$1.25M 0.51%
10,702
-1,513
-12% -$173K
JKHY icon
43
Jack Henry & Associates
JKHY
$11B
$1.01M 0.41%
6,172
-71
-1% -$10.9K
PAYX icon
44
Paychex
PAYX
$42.4B
$982K 0.4%
8,244
-40
-0.5% -$4.74K
EMN icon
45
Eastman Chemical
EMN
$8.54B
$962K 0.39%
10,710
-76
-0.7% -$6.06K
OMC icon
46
Omnicom Group
OMC
$22.6B
$937K 0.38%
10,837
-88
-0.8% -$6.94K
COR icon
47
Cencora
COR
$61.6B
$877K 0.36%
4,269
-53
-1% -$10.3K
PFG icon
48
Principal Financial Group
PFG
$24.6B
$872K 0.36%
11,088
+21
+0.2% +$1.52K
DGX icon
49
Quest Diagnostics
DGX
$26.1B
$864K 0.35%
6,265
-26
-0.4% -$3.42K
INGR icon
50
Ingredion
INGR
$6.56B
$810K 0.33%
7,460
-105
-1% -$10.5K

Similar funds

Martin Capital Partners's Q4 2023 Portfolio in Review

As of Q4 2023, Martin Capital Partners held 73 positions worth $245M, up 3.2% from $238M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Martin Capital Partners's Q4 2023 filing shows 1 new, 7 increased, 57 reduced and 3 closed positions. Its largest new stake was Hormel Foods: 11,507 shares worth $369K. The largest sale was US Bancorp, an estimated $5.27M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Staples.

  • Martin Capital Partners's largest Q4 2023 buy was Hormel Foods: 11,507 shares worth $369K.
  • Martin Capital Partners added most to Cullen/Frost Bankers in Q4 2023, an estimated $3.78M increase.
  • Martin Capital Partners's biggest Q4 2023 reduction was US Bancorp, cutting an estimated $5.27M.
  • Martin Capital Partners fully exited Honeywell in Q4 2023, selling an estimated $4.57M.
  • Martin Capital Partners's ten largest holdings make up 31% of its $245M portfolio in Q4 2023.
  • Martin Capital Partners opened 1 new position and closed 3 in Q4 2023.
  • Martin Capital Partners's portfolio value rose 3.2% quarter-over-quarter to $245M.

Based on Martin Capital Partners's 13F filing for Q4 2023, filed 8 Jan 2024.